Volume 18, Number 5—May 2012
CME ACTIVITY - Research
Invasive Haemophilus influenzae Serotype e and f Disease, England and Wales
Shamez N. Ladhani
, Sarah Collins, Anna Vickers, David J. Litt, Carina Crawford, Mary E. Ramsay, and Mary P.E. Slack
, Sarah Collins, Anna Vickers, David J. Litt, Carina Crawford, Mary E. Ramsay, and Mary P.E. Slack
Table
Characteristics of patients with invasive Hie and Hif infections, England and Wales, 2009–2010*
| Characteristic | Hie, n = 33 | Hif, n = 99 | All, n = 132 | p value |
|---|---|---|---|---|
| Median age, y (IQR) | 62 (6–79) | 65 (46–77) | 65 (41–78) | 0.54 |
| Male sex | 17 (51.5) | 47 (47.5) | 64 (48.5) | 0.69 |
| Underlying conditions | ||||
| 0 | 9 (27.3) | 18 (18.2) | 10 (20.5) | 0.26 |
| 1 | 9 (27.3) | 32 (32.3) | 41 (31.1) | 0.59 |
| >2 | 15 (45.5) | 49 (49.5) | 64 (48.5) | 0.69 |
| Type of underlying condition† | ||||
| Heart disease | 12 (36.4) | 28 (28.3) | 40 (30.3) | 0.38 |
| Lung disease | 7 (21.2) | 28 (28.3) | 35 (26.5) | 0.43 |
| Gastrointestinal disease | 4 (12.1) | 7 (7.1) | 11 (8.3) | 0.36 |
| Renal disease | 6 (18.2) | 12 (12.1) | 18 (13.6) | 0.38 |
| Metabolic/endocrine | 8 (24.2) | 13 (13.1) | 21 (15.9) | 0.13 |
| Malignancy/immunosuppression | 4 (12.1) | 31 (31.3) | 35 (26.5) | 0.031 |
| Neurologic condition | 3 (9.1) | 6 (6.1) | 9 (6.8) | 0.55 |
| Other risk factors‡ | 1 (3.0) | 5 (5.1) | 6 (5.3) | 0.63 |
| Type of Haemophilus influenzae illness | ||||
| Pneumonia | 17 (51.5) | 61 (61.6) | 78 (59.1) | 0.47 |
| Meningitis | 7 (21.2) | 10 (10.1) | 17 (12.9) | 0.099 |
| Septicemia | 2 (6.1) | 16 (16.2) | 18 (13.6) | 0.14 |
| Hepatobiliary infection | 3 (9.1) | 1 (1.0) | 4 (3.0) | 0.019 |
| Septic arthritis | 0 | 4 (4.0) | 4 (3.0) | 0.24 |
| Epiglottitis | 1 (3.0) | 3 (3.0) | 4 (3.0) | 1.00 |
| Cellulitis | 1 (3.0) | 4 (4.0) | 5 (3.8) | 0.79 |
| Urogenital infection | 1 (3.0) | 0 | 1 (0.8) | 0.082 |
| Endocarditis | 1 (3.0) | 0 | 1 (0.8) | 0.082 |
| CFR | ||||
| Overall | 10/33 (41.7) | 34/99 (42.0) | 44/132 (41.9) | 0.98 |
| No underlying condition | 3/9 (33.3) | 0/18 | 3/27 (11.1) | 0.009 |
| 1 underlying condition | 5/24 (20.8) | 9/81 (11.1) | 14/105 (13.3) | 0.22 |
| >2 underlying conditions | 3/15 (20.0) | 7/49 (14.3) | 10/64 (15.6) | 0.59 |
| Attributable CFR | 10/33 (30.3) | 12/99 (12.1) | 22/132 (16.7) | 0.015 |
| CFR within 7 d | 8/33 (24.2) | 8/99 (8.8) | 16/132 (12.1) | 0.014 |
| CFR within 28 d | 10/33 (30.3) | 15/99 (15.2) | 25/132 (18.9) | 0.054 |
| CFR for meningitis§ | 1/7 (14.3) | 0/10 | 1/17 (5.9) | 0.22 |
| CFR for pneumonia§ | 7/17 (41.2) | 7/61 (11.5) | 14/78 (18.0) | 0.005 |
| CFR for septicemia§ | 0/2 | 1/16 (6.3) | 1/18 (5.6) | 0.72 |
| CFR for other conditions§ | 0/7 | 0/12 | 0/19 |
*Values are no. cases (%) or no. cases/no. in category (%), unless otherwise specified. Hie, Haemophilus influenzae serotype e; Hif, H. influenzae serotype f; IQR, interquartile range; CFR, case-fatality ratio.
†Some case-patients had >1 underlying condition.
‡For Hie, long-term complications of extreme prematurity (n = 1); for Hif, alcohol dependency (n = 3), long-term complications of extreme prematurity (n = 1), and schizophrenia (n = 1).
§Death within 7 d.
Page created: April 16, 2012
Page updated: April 16, 2012
Page reviewed: April 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.